Pliant Therapeutics, Inc. (PLRX) Debt by Year
Pliant Therapeutics, Inc. carried $0 in long-term debt against $45.4M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Pliant Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PLRX Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
PLRX Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $0-100.0% | $0-100.0% | $0-100.0% | $30.4M+1.0% | $30.4M+1.0% | $30.3M+0.9% | $30.2M+200.5% | $30.1M+200.8% | $30.1M+201.1% | $30.0M+201.3% | $10.1M+1.3% | $10.0M+1.2% |
| Cash & Equivalents | $24.9M-71.3% | $22.2M-75.9% | $45.4M-36.2% | $93.7M+17.7% | $86.8M+8.0% | $91.9M-19.6% | $71.2M+12.6% | $79.6M+38.0% | $80.4M+46.3% | $114.3M+11.5% | $63.2M+87.7% | $57.7M+29.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Pliant Therapeutics, Inc. financials
Frequently Asked Questions
What was Pliant Therapeutics, Inc.'s long-term debt in fiscal year 2025?
Pliant Therapeutics, Inc. carried $0 in long-term debt against $45.4M in cash and equivalents at the end of fiscal year 2025.
How fast is Pliant Therapeutics, Inc.'s long-term debt growing?
Pliant Therapeutics, Inc. (PLRX) long-term debt fell by 100.0% year over year, from $30.2M to $0 in fiscal year 2025.
What was Pliant Therapeutics, Inc.'s long-term debt in the most recent quarter?
Pliant Therapeutics, Inc. (PLRX) reported $0 in long-term debt in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Pliant Therapeutics, Inc. (PLRX) reported on that line in every period on record.